Blood test may guide depression treatment
NCT ID NCT07269886
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at whether giving doctors extra information from a blood test and genetics could help them choose better medications for people with depression. 79 adults with moderate to severe depression took part. Half of the doctors received this extra information, while the other half provided standard care. The study measured how much depression symptoms improved after 8 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEPRESSION - MAJOR DEPRESSIVE DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Neomente
Buenos Aires, 1425, Argentina
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Eye movements may reveal who benefits from depression medication
- Special forces veterans test Psychedelic-Device combo for PTSD and brain injury
- Fish oil and Body's own healing molecules could lift long COVID depression
- Virtual reality could make depression therapy more immersive and effective
- Brain stimulation plus exercise may lift depression and boost walking after stroke
- Storytelling therapy shows promise for refugee teens' mental health